Current Report Filing (8-k)
September 21 2018 - 12:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): April 18, 2018
ETHEMA HEALTH
CORPORATION
(Exact name
of registrant as specified in its charter)
Colorado
|
000-15078
|
84-1227328
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
810
Andrews Avenue, Delray Beach, Florida 33483
|
(Address
of principal executive offices)
|
(561)
450-7679
|
(Registrant’s
telephone number, including area code)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[
]
|
|
Written
communications pursuant to Rule 425 under the Securities Act
|
[
]
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[
]
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEMS
8.01 OTHER EVENTS
On September 21, 2018 Ethema Health
Corporation (the “Company”), received its probationary licenses for additional levels of care at the Company’s
new facilities in West Palm Beach, Florida. The licences are probationary and are subject to final inspections by the Department
of Children and Family Services (“DCF”) in the next 90 days. This is the normal procedure for new licenses issued
by DCF. The company received licenses for a total of 120 beds including 48 detox beds, 6 intensive inpatient beds and 66 residential
beds. These licenses are in addition to the approval for the relocation of the Company’s existing licenses from Delray Beach
to West Palm Beach for Partial Hospitalization care, Intesnive Outpatient care and Outpatient care. This provides clinets with
a full continuum of care based in its new state of the art facilities in West Palm Beach Florida.
On April 18, 2018, the Company, filed
its amended Annual Report on Form 10-K/A (the “ Annual Report” ). The Annual Report included an incorrect statement
under Item 12 of the report showing Leonite Capital, LLC as being a 5% or larger shareholder. Convertible notes and warrants were
issued to Leonite Capital, LLC and earlier reported in 8K filings on December 7, 2017 and January 8, 2018. The terms of the notes
and warrants issued to Leonite Capital, LLC expressly prohibit Leonite Capital, LLC from ever owning more than 4.99% of the Company’s
outstanding common shares at any one time. Although Leonite Capital, LLC could own stock at different times and from time to time,
that in the aggregate, could total more than 5% of the Company’s common stock, Leonite Capital, LLC is prohibited from owing
more than 4.99% of the Company’s common stock at any one time while those notes and warrants are outstanding.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
Date:
September 21, 2018
By:
/s/ Shawn E. Leon
Name:
Shawn E. Leon
Title:
CEO
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ethema Health (PK) (USOTC:GRST)
Historical Stock Chart
From Apr 2023 to Apr 2024